Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

    ... Our results show that routine BM flow cytometry , morphology and cytogenetics, in patients who present with cytopenia ...

    Research Article last updated 11/25/2014 - 9:57am.

  2. Multicentre validation of a reproducible flow cytometric score for the diagnosis of low-risk myelodysplastic syndromes: results of a European LeukemiaNET study

    ... diagnosis of myelodysplastic syndrome, especially when morphology and cytogenetics are indeterminate. ...

    Research Article last updated 06/15/2012 - 1:53pm.

  3. Phase I, Dose Escalation Study of Decitabine

    ... bone marrow leukemic blasts less than 5% by morphology ), with high risk features including: Status post allogeneic ...

    Clinical Trial last updated 06/06/2016 - 9:44am.

  4. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... lived. Acute Leukemias: Must be in remission by morphology (<5% blasts ). Note cytogenetic relapse or persistent ... be < 5% by a representative bone marrow aspirate morphology. Large-cell lymphoma, Hodgkin lymphoma and multiple myeloma with ...

    Clinical Trial last updated 04/29/2016 - 10:06am.

  5. MDS and MDS/MPN: Past, Present, and Future 2014 American Society of Hematology (ASH) Satellite Symposium Summary for Patients and Families

    ... Diagnosis of MDS or MDS/MPN must begin with morphology (analysis of the form and structure of patient blood or bone ...

    Page last updated 03/13/2015 - 5:00pm.

  6. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

    ... Megakaryocyte proliferation with large and mature morphology . No significant increase or left shift of neutrophil ...

    Clinical Trial last updated 05/02/2016 - 2:31pm.

  7. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

    ... Megakaryocyte proliferation with large and mature morphology . No or little granulocyte or erythroid proliferation. ...

    Clinical Trial last updated 04/29/2016 - 9:59am.

  8. Allo HSCT Using RIC for Hematological Diseases

    ... MDS . Blasts must be < 5% by bone marrow aspirate morphology . Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  9. The Pathologist’s Role in an MDS Diagnosis

    ... to the disease. MDS is a diverse disease in terms of morphology with many reactive mimics. Although most often the bone ... is obtained after repeated transfusions, which can alter the morphology and confound the interpretation. And I must mention there are ...

    Interview last updated 01/28/2014 - 1:47pm.

  10. Understanding Prognosis in MDS

    ... for other known prognostic factors. Pathology, morphology , and the significance of transfusions are all part of the ...

    Interview last updated 05/02/2012 - 4:36pm.